3-[(4-bromo-3-methylphenyl)diazenyl]-5,7-difluoro-1-(thietan-3-yl)indol-2-ol
C18H14BrF2N3OS — CID 136867785
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(4-bromo-3-methylphenyl)diazenyl]-5,7-difluoro-1-(thietan-3-yl)indol-2-ol
3-[(4-bromo-3-methylphenyl)diazenyl]-5,7-difluoro-1-(thietan-3-yl)indol-2-ol (PubChem CID 136867785) has the molecular formula C18H14BrF2N3OS and a molecular weight of 438.30 g/mol. Its IUPAC name is 3-[(4-bromo-3-methylphenyl)diazenyl]-5,7-difluoro-1-(thietan-3-yl)indol-2-ol.
Molecular Properties
| Compound Name | 3-[(4-bromo-3-methylphenyl)diazenyl]-5,7-difluoro-1-(thietan-3-yl)indol-2-ol |
|---|---|
| PubChem CID | 136867785 |
| Molecular Formula | C18H14BrF2N3OS |
| Molecular Weight | 438.30 g/mol |
| Exact Mass | 437.00 |
| IUPAC Name | 3-[(4-bromo-3-methylphenyl)diazenyl]-5,7-difluoro-1-(thietan-3-yl)indol-2-ol |
| SMILES | Cc1cc(/N=N/c2c(O)n(C3CSC3)c3c(F)cc(F)cc23)ccc1Br |
| InChI | InChI=1S/C18H14BrF2N3OS/c1-9-4-11(2-3-14(9)19)22-23-16-13-5-10(20)6-15(21)17(13)24(18(16)25)12-7-26-8-12/h2-6,12,25H,7-8H2,1H3/b23-22+ |
| InChIKey | WRFGIYIYGVQRRW-GHVJWSGMSA-N |
| XLogP | 6.40 |
| TPSA | 49.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.30 |
| LogP ≤ 5 | 6.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 136867785 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.